All you need to know about high-bleeding risk (HBR) patients

Chairpersons: M. C. Morice, P. Urban
SHOW MORE

Summary

Consult this session to learn more about current evidence and new recommendations on high bleeding risk patients and how to better identify them.

Learning Objectives

  • To better identify high bleeding risk patients
  • To discuss current evidence and new recommendations

Presentations available when logged in:

  • Session objectives
  • Background and clinical data: patients at high bleeding risk, the forgotten population
  • Guidelines and recommendations: the ARC HBR initiative
  • Clinical issues and technical aspects in HBR patients: the tradeoff between bleeding and thrombosis
  • Unresolved issues and outlook: which DAPT length for HBR?